Türkiye's Deva sees year-end result matching h1 growth

Reuters - Deva Holding expects to retain its first six-month sale performance by the end of 2010, chief executive Philipp Haas said on Thursday. The volume of sales expanded 13.58 percent in the first half. The Istanbul-based pharmaceuticals company will put two new production lines into operation this year, said Haas.

Deva; Philipp Haas; generic drug; pharmaceuticals